coalition epidemic preparedness innovations cepi foundation takes donations public private philanthropic civil society organisations finance independent research projects develop vaccines emerging infectious diseases cepi focused world health organizations blueprint priority diseases include middle east respiratory syndromerelated coronavirus merscov severe acute respiratory syndrome coronavirus nipah virus lassa fever virus rift valley fever virus well chikungunya virus hypothetical unknown pathogen disease cepi investment also requires equitable access vaccines outbreaks although subsequent cepi policy changes may compromised cepi adopted vision world able respond pandemic threat new vaccine within cepi conceived formally launched world economic forum wef davos switzerland cofounded cofunded million bill melinda gates foundation wellcome governments india norway later joined european union united kingdom cepi headquartered oslo concept cepi outlined july paper new england journal medicine titled establishing global vaccinedevelopment fund coauthored british medical researcher jeremy farrar director wellcome trust american physician stanley plotkin codiscoverer rubella vaccine american expert infectious diseases adel mahmoud developer hpv vaccine rotavirus concept expanded wef davos discussed solution problems encountered developing distributing vaccine western african ebola virus cofounder funder bill gates said market going solve problem epidemics come along often allowed charge huge premium price tools cepis creation also supported cofunded pharmaceutical industry including glaxosmithkline gsk ceo sir andrew witty explaining wef superdisruptive red phone rings vaccine division health emergency people realise theres spare capacity worlds vaccine production system cepi formally launched wef davos initial investment million consortium included governments norway japan germany wellcome trust gates india joined short time launch interview financial times ft gates said key goal reduce time develop vaccines years less initial targets six eid viruses known potential cause major epidemics mers lassa fever nipah virus ebola marburg fever ft reported cepi would build scientific technological infrastructure developing vaccines quickly pathogens emerge nowhere cause global health crisis sars zika fund research papers costs process vaccine town country listed one newsworthy moments launch norwegian physician johnarne røttingen led steering committee ebola vaccine trials served interim ceo cepi based norwegian institute public health april richard j hatchett former director us governments biomedical advanced research development authority barda became fulltime hatchett also member united states homeland security council george w bush united states national security council barack also april cepi opened additional office london october office opened washington nature later stated far largest vaccine development initiative ever viruses potential epidemic cepi identified several media outlets key player race develop vaccine coronavirus disease launch cepi announced fiveyear financial pledges founders amounted million came sovereign governments japan million norway million germany million alone later became million global foundations gates foundation million wellcome trust million india finalising financial commitment made shortly funding target billion set first years operation ie january journal nature said amount raised far largest vaccine development initiative ever viruses potential epidemic part funding structure cepi used vaccine bonds frontload multiyear sovereign funding pledges international finance facility immunisation iffim issued nok million vaccine bonds frontload commitment norway gavi vaccine alliance march european commission granted access cepi eus horizon programme longerterm financial funding cepi note presentations eus financial commitment amounts million added seed amount including full german commitment came february bloomberg news reported cepi raised total million additional donations governments australia belgium canada bloomberg said cepi solves economists call coordination problem help pair boutique research development companies big vaccine manufacturers work regulators streamline approval processes resolve patent disputes spot scientific advisory committee executives pfizer johnson johnson japans takeda pharmaceutical among march british government pledged million funding cepi specifically focus vaccine coronavirus making britain cepis largest individual january wellcome trust bill melinda gates foundation pledged million part cepis effort enable world reduce vaccine development timelines days founding mission cepi equitable access pandemics selling vaccines developing nations affordable affordable access existing patented vaccines long concern medical community concern mounted wake struggle get access vaccine ebola averting repetition crisis motivating factor behind founding cepis original contained specific measures prevent market problems vaccinemanufacturing contracts would need initial approval public review board policy also stated vaccine prices would set levels affordable needing vaccines sustainable trade secrets would funded cepi companies share research data developed cepi funds cepi would controversially retain license intellectual property developed cepi funds allowing groups awarded funding cepi retained stepin rights right license use intellectual property developed cepi funds vaccine production even company received funding taken ownership ip later withdrew agreement original policy also required funded parties preregister trials clinical trials registry publish results within year study completion except compelling reason permission cepi publish results openaccess articles mechanisms securely sharing underlying data results including negative results way preserves trial volunteer privacy see alltrials pharmaceutical corporations including johnson johnson pfizer takeda objected original policy provisions removed december cepi obtained significant policy changes met strong criticism led médecins sans cepi also criticized following policies transparency removing requirement cepis board review cepis cepi stated vaccines would continue affordable published article discussing changes saying old policy reflective idealism inspired creation cepi felt others pragmatic reflect business realities confronted vaccine said several unnamed vaccine manufacturers declared could work cepi original policy said policy change reflect change commitment access cepi would still retain right research development using intellectual property funded old partner unable continue also said cepi would retain right find new manufacturer old manufacturer could continue provided old manufacturer agrees transfer information intellectual property new new york times said cepi made failed effort get large pharmaceutical firms agree partners without insisting substantial profits proprietary rights research cepi helped finance produce replaced specific implementation measures lip service funding coalition nominated nobel peace prize norwegian mp carlerik cepi incorporated norwegian law march fulltime staff runs organisation direction chief executive officer richard october cepi scientists estimated costs developing least one vaccine diseases could escalate global humanitarian crises billion november cepi discussed target portfolio whos blueprint priority diseases included merscov nipah virus lassa fever virus rift valley fever virus well chikungunya virus whos disease cepi outlined projects update cepi priorities establishment technical regulatory pathways vaccine development develop sustainable manufacturing solutions vaccine candidates nearing completion create investigatory stockpiles vaccine candidates use emergency httpsenwikipediaorgwikicoalitionforepidemicpreparednessinnovations